Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)

Anaesthesia Critical Care and Pain Medicine

Volumn 35, Issue 2, 2016, Pages 151-165

  Ichai, Carole ^a   Vinsonneau, Christophe ^b   Souweine, Bertrand ^a   Armando, Fabien ^c   Canet, Emmanuel ^d,r   Clec'h, Christophe ^e,r   Constantin, Jean Michel ^c,r   Darmon, Michaël ^f,r   Duranteau, Jacques ^g,r   Gaillot, Théophille ^h,r   Garnier, Arnaud ^i,r   Jacob, Laurent ^d,r   Joannes Boyau, Olivier ^j,r   Juillard, Laurent ^k,r   Journois, Didier ^l,r   Lautrette, Alexandre ^m,r   Muller, Laurent ^n,r   Legrand, Matthieu ^d,r   Lerolle, Nicolas ^o,r   Rimmelé, Thomas ^k,r   Rondeau, Eric ^l,r   Tamion, Fabienne ^p,r   Walrave, Yannick ^a   Velly, Lionel ^q   Fletcher, D ^r   Velly, L ^r   Amour, J ^r   Ausset, S ^r   Chanques, G ^r   Compere, V ^r   Espitalier, F ^r   Garnier, M ^r   Gayat, E ^r   Lefrant, J Y ^r   Malinovski, J M ^r   Rozec, B ^r   Tavernier, B ^r,r   Donetti, L ^r   Alves, M ^r   Tboulain, ^r   Rissaud, Olivier B ^r   Das, V ^r   De Saint, L ^r   Blanquat, ^r   Guillot, M ^r   Kuteifan, K ^r   Mathien, C ^r   Peigne, V ^r   Plouvier, F ^r   Schnell, D ^r   Vong, L ^r   Ecoffey, C ^r   Bonnet, F ^r   Capdevila, X ^r   Bouaziz, H ^r   Albaladejo, P ^r   Delaunay, L ^r   Cittanova Pansard, M L ^r   Al Nasser, B ^r   Arnaud, C M ^r   Beaussier, M ^r   Chariot, M ^r   Constantin, J M ^r   Gentili, M ^r   Delbos, A ^r   Dumeix, J M ^r   Estebe, J P ^r   Langeron, O ^r   Mercadal, L ^r   Ripart, J ^r   Samama, M ^r   Sleth, J C ^r   Viel, E ^r   Zetlaoui, P ^r   Laterre, P F ^r   Mira, J P ^r   Pugin, J ^r   Monnet, X ^r   Luyt, C E ^r   Diehl, J L ^r   Dauger, S ^r   Dellamonica, J ^r   Levy, B ^r   Megarbane, B ^r   Misset, Pr Benoit ^r   Outin, H ^r   Tamion, F ^r   Valera, S ^r   more..

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b Hopital Marc Jacquet   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e AVICENNE HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^g BICÊTRE HOSPITAL   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

ⁱ HÔPITAL DES ENFANTS   (France)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k EDOUARD HERRIOT HOSPITAL   (France)

^l ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^m SERVICE DE RHUMATOLOGIE   (France)

ⁿ DEPARTMENT OF NEUROLOGY   (France)

^o ANGERS UNIVERSITY HOSPITAL   (France)

^p HÔPITAL CHARLES NICOLLE   (France)

^q TIMONE HOSPITAL   (France)

^r NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; CONVALESCENCE; DISEASE SEVERITY; DRUG SAFETY; EARLY DIAGNOSIS; FLUID THERAPY; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; NUTRITIONAL SUPPORT; PATIENT CARE; PERIOPERATIVE PERIOD; PHARMACEUTICAL CARE; PREVENTIVE MEDICINE; PROTEIN INTAKE; RISK ASSESSMENT; TREATMENT PLANNING; ACUTE KIDNEY INJURY; DIET THERAPY; INTENSIVE CARE; PATHOPHYSIOLOGY; PROCEDURES; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; CRITICAL CARE; HUMANS; INTENSIVE CARE UNITS; NUTRITION THERAPY; PERIOPERATIVE CARE; RENAL REPLACEMENT THERAPY;

EID: 84973171232     PISSN: None     EISSN: 23525568     Source Type: Journal    
DOI: 10.1016/j.accpm.2016.03.004     Document Type: Article

References (225)

1. The Kidney Disease Improving Global Outcomes (KDIGO) Working Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012, 2:1-138.
2. Hoste E.A., Damen J., Vanholder R.C., et al. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005, 20:747-753.
3. Kellum J.A., Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 2013, 17:204.
4. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
5. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
6. Uchino S., Bellomo R., Goldsmith D., Bates S., Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006, 34:1913-1917.
7. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10:R73.
8. Bagshaw S.M., George C., Dinu I., Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008, 23:1203-1210.
9. Joannidis M., Metnitz B., Bauer P., et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009, 35:1692-1702.
10. Coca S.G., Singanamala S., Parikh C.R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012, 81:442-448.
11. Akcan-Arikan A., Zappitelli M., Loftis L.L., Wasburn K.K., Jefferson L.S., Goldstein S.L. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007, 71:1028-1035.
12. Schwartz G.J., Brion L.P., Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987, 34:57-90.
13. Plötz F., Bouma A., van Wijk J., Kneyber M., Bökenkamp A. Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med 2008, 34:1713-1717.
14. Bonventre J.V., Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011, 121:4210-4221.
15. Bellomo R., Kellum J.A., Ronco C. Acute kidney injury. Lancet 2012, 380:7556-7566.
16. Chertow G.M., Burdock E., Honour M., et al. Acute kidney injury, mortality, length of stay and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
17. Wald R., Quinn R.R., Luo J., et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009, 302:1179-1185.
18. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
19. Waikar S.S., Liu K.D., Chertow G.M. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008, 3:844-861.
20. Nisula S., Kaukonen K.-M., Vaara S.T., et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 2013, 39:420-428.
21. Vaara S.T., Pettilä V., Reinkainen M., Kaukonen K.-M., for the Finnish Intensive Care Corsortium Population-based incidence, and mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in Finnish intensive care units. Crit Care 2012, 16:R13.
22. Endre Z.H., Pickering J.W., Walker R.J. Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am J Physiol Renal Physiol 2011, 301:F697-F707.
23. Murray P.T., Mehta R.L., Shaw A., et al. Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative Consensus Conference. Kidney Int 2014, 85:513-521.
24. Bihorac A., Kellum J.A. Acute kidney injury in 2014: a step towards understanding mechanism of renal repair. Natl Rev Nephrol 2015, 11:74-75.
25. Cruz D.N., Mehta R.L. Acute kidney injury in 2013: breaking barriers for biomarkers in AKI-progress at last. Nat Rev Neprhol 2014, 10:74-76.
26. Parikh C.R., Devarajan P. New biomarkers in acute kidney injury. Crit Care Med 2008, 36S159-65S.
27. Shang Z., Lu B., Sheng X., Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2011, 58:356-365.
28. Liu Y., Guo W., Zhang J., et al. Urinary interleukin 18 for detection of acute kidney injury: a metanalysis. Am J kidney Dis 2013, 62:1058-1067.
29. Shao X., Tian L., Xu W., et al. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. Plos One 2014, 9:e84131.
30. Haase M., Bellomo R., Devarajan P., et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024.
31. Haase M., Devarajan P., Haase-Fielitz A., et al. The outcome of of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury. JACC 2011, 57:1752-1761.
32. Kashani K., Al-Khafaji A., Ardiles T., et al. Discovery and validation of cell cycle arrrest biomarkers in human acute kidney injury. Crit Care 2013, 17:R25.
33. Bihorac A., Chawla L.S., Shaw A.D., et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Resp Crit Care Med 2014, 189:932-939.
34. McIllroy D.R., Epi M.C., Wagener G., Lee H.T. Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 2010, 112:998-1004.
35. Goldstein S.L. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 2012, 33:131-137.
36. Schiffl H., Lang S. Urinary biomarkers and acute kidney injury in children: the long road to clinical application. Pediatr Nephrol 2013, 28:837-842.
37. Ataei N., Bazargani B., Sonbol A., et al. Early detection of acute kidney injury by serum cystatin C in critically ill children. Pediatr Nephrol 2014, 29:133-138.
38. Schnell D., Darmon M. Renal Doppler to assess renal perfusion in the critically ill: a reappraisal. Intensive Care Med 2012, 38:1751-1760.
39. Duranteau J., Deruddre S., Vigue B., Chemla D. Doppler monitoring of renal hemodynamics: why the best is yet to come. Intensive Care Med 2008, 34:1360-1361.
40. Wan L., Yang N., Hiew C.-Y., et al. An assessment of the accuracy of renal blood flow estimation by Doppler ultrasound. Intensive Care Med 2008, 34:1503-1510.
41. Lauschke A., Teichgräber U.K.M., Frei U., Eckardt K.U. "Low-dose" dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006, 69:1669-1674.
42. Deruddre S., Cheisson G., Mazoit J.X., et al. Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Med 2007, 33:1557-1562.
43. Schnell D., Camous L., Guyomarc'h S., et al. Renal perfusion assessment by renal doppler during fluid challenge in sepsis. Crit Care Med 2013, 41:1214-1220.
44. Lerolle N., Guérot E., Faisy C., et al. Renal failure in septic shock: predictive value of Doppler-based renal arterial resistive index. Intensive Care Med 2006, 32:1553-1555.
45. Platt J.F., Rubin J.M., Ellis J.H. Acute renal failure: possible role of duplex Doppler US in distinction between acute prerenal failure and acute tubular necrosis. Radiology 1991, 179:419-423.
46. Izumi M., Sugiura T., Nakamura H., et al. Differential diagnosis of prerenal azotemia from acute tubular necrosis and prediction of recovery by Doppler ultrasound. Am J Kidney Dis 2000, 35:713-719.
47. Stevens P.E., Gwyther S.J., Hanson M.E., et al. Noninvasive monitoring of renal blood flow characteristics during acute renal failure in man. Intensive Care Med 1990, 16:153-158.
48. Schnell D., Deruddre S., Harrois A., et al. Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C. Shock 2012, 38:592-597.
49. Darmon M., Schortgen F., Vargas F., et al. Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Med 2011, 37:68-76.
50. Schnell D., Reynaud M., Venot M., et al. Resistive index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot study. Minerva Anestesiol 2014, 80:1273-1281.
51. Bossard G., Bourgoin P., Corbeau J.J., et al. Early detection of postoperative acute kidney injury by Doppler renal resistive index in cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2011, 107:891-898.
52. Dewitte A., Coquin J., Meyssignac B., et al. Doppler resistive index to reflect regulation of renal vascular tone during sepsis and acute kidney injury. Crit Care 2012, 16:R165.
53. Lerolle N. Please don't call me RI anymore; I may not be the one you think I am!. Crit Care 2012, 16:174.
54. Bude R.O., Rubin J.M. Relationship between the resistive index and vascular compliance and resistance. Radiology 1999, 211:411-417.
55. Murphy M.E., Tublin M.E. Understanding the Doppler RI: impact of renal arterial distensibility on the RI in a hydronephrotic ex vivo rabbit kidney model. J Ultrasound Med 2000, 19:303-314.
56. Tublin M.E., Tessler F.N., Murphy M.E. Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys. Radiology 1999, 213:258-264.
57. Naesens M., Heylen L., Lerut E., et al. Intrarenal resistive index after renal transplantation. N Engl J Med 2013, 369:1797-1806.
58. Huen S.C., Parikh C.R. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg 2012, 93:337-347.
59. Kheterpal S., Tremper K.K., Heung M., et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009, 110:505-515.
60. Pannu N., Nadim M.K. An overview of drug-induced acute kidney injury. Crit Care Med 2008, 36:5216-5223.
61. Bentley M.L., Corwin H.I., Dasta J., et al. Drug-induced acute kidney injury in the critically ill adult: recognition and preventive strategies. Crit Care Med 2010, 38(Suppl. 6):5169-5174.
62. Annane D., Siami S., Jaber S., et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013, 310:1809-1817.
63. Myburgh J.A., Finfer S., Bellomo R., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367:1901-1911.
64. Haase N., Perner A., Hennings L.I., et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013, 346:f839.
65. Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134.
66. Zarychanski R., Abou-Setta A.M., Turgeon A.F., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013, 309:678-688.
67. Guidet B., Martinet O., Boulain T., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012, 16:R94.
68. Patel A., Waheed U., Brett S.J. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013, 39:811-822.
69. Hartog C.S., Reinhart K. CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients. Crit Care 2012, 16:454.
70. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
71. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357:911-916.
72. Perel P., Roberts I., Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013, 2:CD000567.
73. Mutter T.C., Ruth C.A., Dart A.B. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2013, 7:CD007594.
74. Martin C., Jacob M., Vicaut E., et al. Effect of waxy maize-derived hydroxyethyl Starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013, 118:387-394.
75. accessed 27 January 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Hydroxyethyl_starch-containing_solutions/human_referral_prac_000012.jsp%26mid=WC0b01ac05805c516f.
76. Kurtz T.W., Morris R.C. Dietary chloride as a determinant of "sodium-dependent" hypertension. Science 1983, 222:1139-1141.
77. Wilcox C.S. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983, 71:726-735.
78. Hansen P.B., Jensen B.L., Skott O. Chloride regulates afferent arteriolar contraction in response to depolarization. Hypertension 1998, 32:1066-1070.
79. ® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012, 256:18-24.
80. Lobo D.N., Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent 'pre-renal' acute kidney injury?. Kidney Int 2014, 86:1096-1105.
81. Yunos N.M., Kim I.B., Bellomo R., et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med 2011, 39:2419-2424.
82. Shaw A.D., Bagshaw S.M., Goldstein S.L., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012, 255:821-829.
83. Yunos N.M., Bellomo R., Hegarty C., Story D., Ho L., Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012, 308:1566-1572.
84. McCluskey S.A., Karkouti K., Wijeysundera D., Minkovich L., Tait G., Scott Beattie W. Hyperchloremia after non-cardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 2013, 13:412-421.
85. Raghunathan K., Shaw A., Nathanson B., et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 2014, 40:1897-1905.
86. Krajewski M.L., Raghunathan K., Paluszkiewicz S.M., Schermer C.R., Shaw A.D. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg 2015, 102:24-36.
87. Raghunathan K., Murray P.T., Beattie W.S., et al. Choice of fluid in acute illness: what should be given? An international consensus. Br J Anaesth 2014, 113:772-783.
88. Antonelli M., Levy M., Andrews P.J., et al. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med 2007, 33:575-590.
89. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228.
90. Varpula M., Tallgren M., Saukkonen K., Voipio-Pulkki L.M., Pettila V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31:1066-1071.
91. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
92. Poukkanen M., Wilkman E., Vaara S.T., et al. Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care 2013, 17:R295.
93. Asfar P., Meziani F., Hamel J.F., et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014, 370:1583-1593.
94. Bourgoin A., Leone M., Delmas A., Garnier F., Albanese J., Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33:780-786.
95. LeDoux D., Astiz M.E., Carpati C.M., Rackow E.C. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
96. Dunser M.W., Takala J., Ulmer H., et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med 2009, 35:1225-1233.
97. Benchekroune S., Karpati P.C., Berton C., et al. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock. J Trauma 2008, 64:1188-1195.
98. Legrand M., Dupuis C., Simon C., et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 2013, 17:R278.
99. Walsh M., Devereaux P.J., Garg A.X., et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013, 119:507-515.
100. Haase M., Bellomo R., Story D., et al. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transplant 2012, 27:153-160.
101. Kanji H.D., Schulze C.J., Hervas-Malo M., et al. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg 2010, 5:71.
102. Brienza N., Giglio M.T., Marucci M., Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009, 37:2079-2090.
103. Grocott M.P., Dushianthan A., Hamilton M.A., Mythen M.G., Harrison D., Rowan K. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review. Br J Anaesth 2013, 111:535-548.
104. Bouchard J., Soroko S.B., Chertow G.M., et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009, 76:422-427.
105. Payen D., de Pont A.C., Sakr Y., Spies C., Reinhart K., Vincent J.L. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008, 12:R74.
106. Teixeira C., Garzotto F., Piccinni P., et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013, 17:R14.
107. Grams M.E., Estrella M.M., Coresh J., Brower R.G., Liu K.D. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011, 6:966-973.
108. Bellomo R., Cass A., Cole L., et al. An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med 2012, 40:1753-1760.
109. Boland M.R., Noorani A., Varty K., Coffey J.C., Agha R., Walsh S.R. Perioperative fluid restriction in major abdominal surgery: systematic review and meta-analysis of randomized, clinical trials. World J Surg 2013, 37:1193-1202.
110. Varadhan K.K., Lobo D.N. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc 2010, 69:488-498.
111. Desjars P., Pinaud M., Bugnon D., Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989, 17:426-429.
112. Desjars P., Pinaud M., Potel G., Tasseau F., Touze M.D. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987, 15:134-137.
113. Fukuoka T., Nishimura M., Imanaka H., Taenaka N., Yoshiya I., Takezawa J. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989, 17:1104-1107.
114. Martin C., Viviand X., Leone M., Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000, 28:2758-2765.
115. Redl-Wenzl E.M., Armbruster C., Edelmann G., et al. Noradrenaline in the "high output-low resistance" state of patients with abdominal sepsis. Anaesthesist 1990, 39:525-529.
116. Albanese J., Leone M., Garnier F., Bourgoin A., Antonini F., Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004, 126:534-539.
117. Martin C., Papazian L., Perrin G., Saux P., Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest 1993, 103:1826-1831.
118. Leone M., Albanese J., Delmas A., Chaabane W., Garnier F., Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004, 22:314-319.
119. Albanese J., Leone M., Delmas A., Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005, 33:1897-1902.
120. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002, 105:2259-2264.
121. Rudnick M.R., Goldfarb S., Tumlin J. Contrast-induced nephropathy: is the picture any clearer?. Clin J Am Soc Nephrol 2008, 3:261-262.
122. Hoste E.A.J., Doom S., De Waele J., et al. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 2011, 37:1921-1931.
123. Chousterman B.G., Bouadma L., Moutereau S., et al. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results. J Crit Care 2013, 5:701-709.
124. Valette X., Savary B., Nowoczyn M., et al. Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness. Intensive Care Med 2013, 39:857-865.
125. Clec'h C., Razafimandimby D., Laouisset M., et al. Incidence and outcome of contrast-associated acute kidney injury in a mixed medical-surgical ICU population: a retrospective study. BMC Nephrol 2013, 4:14-31.
126. Brar S.S., Hiremath S., Dangas G., et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009, 4:1584-1592.
127. Zoungas S., Ninomiya T., Huxley R., et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009, 151:631-638.
128. Brown J.R., Block C.A., Malenka D.J., et al. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv 2009, 2:1116-1124.
129. Sun Z., Fu Q., Cao L., et al. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PloS One 2013, 8:e55124.
130. Jang J.S., Jin H.Y., Seo J.S., et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury - a systematic review and meta-analysis. Circ J 2012, 76:2255-2265.
131. Solomon R., Werner C., Mann D., et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994, 331:1416-1420.
132. Vaitkus P.T., Brar C. N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. Am Heart J 2007, 153:275-280.
133. Hoste E.A.J., De Waele J.J., Gevaert S.A., Uchino S., Kellum J.A. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant 2010, 25:747-758.
134. Klima T., Christ A., Marana I., et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. Eur Heart J 2012, 33:2071-2079.
135. Kooiman J., Sijpkens Y.W.J., de Vries J-PPM, et al. A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. Nephrol Dial Transplant 2014, 29:1029-1036.
136. Pattharanitima P., Tasanarong A. Pharmacological strategies to prevent contrast-induced acute kidney injury. BioMed Res Int 2014, 2014:236930.
137. Kelly A.M., Dwamena B., Cronin P., et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008, 148:284-294.
138. McCullough P. Radiocontrast-induced acute kidney injury. Nephron Physiol 2008, 109:61-72.
139. Kellum J., Leblanc M., Venkataraman R. Acute renal failure. BMJ Clin Evid 2008, 9:2001.
140. Rybak M.J., Abate B.J., Kang S.L., et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 1999, 43:1549-1555.
141. Bailey T.C., Little J.R., Littenberg B., et al. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997, 24:786-795.
142. Hatala R., Dinh T., Cook D.J. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996, 124:717-725.
143. Wargo K.A., Edwards J. Aminoglycoside-induced nephrotoxicity. J Pharm Pract 2014, 27:573-577.
144. Picard W., Bazin F., Clouzeau B., et al. Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock. Antimicrob Agents Chemother 2014, 58:7468-7474.
145. Boyer A., Gruson D., Bouchet S., et al. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Drug Saf 2013, 36:217-230.
146. Croes S., Koop A.H., van Gils S.A., Neef C. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Eur J Pharm 2012, 45:90-100.
147. Pagkalis S., Mantadakis E., Mavros M.N., et al. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 2011, 71:2277-2294.
148. Oliveira J.F.P., Silva C.A., Barbieri C.D., et al. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother 2009, 53:2887-2891.
149. Selby N.M., Shaw S., Woodier N., et al. Gentamicin-associated acute kidney injury. QJM 2009, 102:873-880.
150. Bartal C., Danon A., Schlaeffer F., et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med 2003, 114:194-198.
151. Perazella M.A. Drug use and nephrotoxicity in the intensive care unit. Kidney Int 2012, 81:1172-1178.
152. Papadopoulos J., Smithburger P.L. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. Crit Care Med 2010, 38:S126-S135.
153. Schetz M., Dasta J., Goldstein S., Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care 2005, 11:555-565.
154. Ho K.M., Power B.M. Benefits and risks of furosemide in acute kidney injury. Anaesthesia 2010, 63:283-294.
155. Ho K.M., Sheridan D.J. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006, 333:420.
156. Haase M., Fielitz A.H., Plass M., et al. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. Plos One 2013, 10:e1001426.
157. Kristeller J.L., Zavorsky G.S., Prior J.E., et al. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial. Pharmacotherapy 2013, 3:710-717.
158. McGuinness S.P., Parke R.L., Bellomo R., Van Haren F.M.P., Bailey M. Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med 2013, 41:1599-1607.
159. Hewitt J., Uniacke M., Hansi N.K., Venkat-Raman G., McCarthy K. Sodium bicarbonate supplements for treating acute kidney injury. Cochrane Database Syst Rev 2012, 6:CD009204.
160. Bosch X., Poch E., Grau J.M. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009, 361:62-72.
161. Chatzizisis Y.S., Misirli G., Hatzitolios A.I., Giannoglou G.D. The syndrome of rhabdomyolysis: complications and treatment. Eur J Intern Med 2008, 19:568-574.
162. Scharman E.J., Troutman W.G. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother 2013, 47:90-105.
163. Shimazu T., Yoshioka T., Nakata Y., et al. Fluid resuscitation and systemic complications in crush syndrome: 14 Hanshin-Awaji earthquake patients. J Trauma 1997, 42:641-646.
164. Gunal A.I., Celiker H., Dogukan A., et al. Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes. J Am Soc Nephrol 2004, 15:1862-1867.
165. Homsi E., Barreiro M.F., Orlando J.M., Higa E.M. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997, 19:283-288.
166. Brown C.V.R., Rhee P., Chan L., Evans K., Demetriades D., Velmahos G.C. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. J Trauma 2004, 56:1191-1196.
167. Cho Y.S., Lim H., Kim S.H. Comparison of lactated Ringer's solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication. Emerg Med J 2007, 24:276-280.
168. Yallop K.G., Sheppard S.V., Smith D.C. The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine. Anaesthesia 2008, 63:576-582.
169. Smith M.N.A., Best D., Sheppard S.V., Smith D.C. The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction. Anaesthesia 2008, 63:701-704.
170. Majumdar S.R., Kjellstrand C.M., Tymchak W.J., Hervas-Malo M., Taylor D.A., Teo K.K. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis 2009, 54:602-609.
171. Friedrich J.O., Adhikari N., Herridge M.S., Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005, 142:510-524.
172. Kellum J.A., Decker M.J. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001, 29:1526-1531.
173. Bellomo R., Chapman M., Finfer S., Hickling K., Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356:2139-2143.
174. Stone G.W., McCullough P.A., Tumlin J.A., et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003, 290:2284-2291.
175. Caimmi P.-P., Pagani L., Micalizzi E., et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003, 17:491-494.
176. Bove T., Landoni G., Calabrò M.G., et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005, 111:3230-3235.
177. Brienza N., Malcangi V., Dalfino L., et al. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 2006, 34:707-714.
178. Ranucci M., Soro G., Barzaghi N., et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 2004, 78:1332-1337.
179. Tumlin J.A., Finkel K.W., Murray P.T., Samuels J., Cotsonis G., Shaw A.D. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005, 46:26-34.
180. Morelli A., Ricci Z., Bellomo R., et al. Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 2005, 33:2451-2456.
181. Patel N.N., Rogers C.A., Angelini G.D., Murphy G.J. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev 2011, 16:553-567.
182. Landoni G., Biondi-Zoccai G.G.L., Marino G., et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2008, 22:27-33.
183. Landoni G., Biondi-Zoccai G.G.L., Tumlin J.A., et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007, 49:56-68.
184. Zangrillo A., Biondi-Zoccai G.G.L., Frati E., et al. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth 2012, 26:407-413.
185. Sackner-Bernstein J.D., Skopicki H.A., Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487-1491.
186. Nigwekar S.U., Navaneethan S.D., Parikh C.R., Hix J.K. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009, 4:261-272.
187. Mitaka C., Kudo T., Haraguchi G., Tomita M. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care 2011, 15:R258.
188. Nigwekar S.U., Navaneethan S.D., Parikh C.R., Hix J.K. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev 2009, 4:CD006028.
189. Adabag A.S., Ishani A., Bloomfield H.E., Ngo A.K., Wilt T.J. Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart J 2009, 30:1910-1917.
190. Duong M.H., MacKenzie T.A., Malenka D.J. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv 2005, 64:471-479.
191. Ho K.M., Morgan D.J.R. Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. Am J Kidney Dis 2009, 53:33-40.
192. Nigwekar S.U., Kandula P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg 2009, 87:139-147.
193. Hirschberg R., Kopple J., Lipsett P., et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999, 55:2423-2432.
194. Hladunewich M.A., Corrigan G., Derby G.C., et al. A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int 2003, 64:593-602.
195. Endre Z.H., Walker R.J., Pickering J.W., et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010, 77:1020-1030.
196. Song Y.R., Lee T., You S.J., et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009, 30:253-260.
197. Gottlieb S.S., Brater D.C., Thomas I., et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002, 105:1348-1353.
198. Givertz M.M., Massie B.M., Fields T.K., Pearson L.L., Dittrich H.C., CKI-201 and CKI-202 Investigators The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 2007, 50:1551-1560.
199. Massie B.M., O'Connor C.M., Metra M., et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010, 363:1419-1428.
200. Howard S.C., Jones D.P., Pui C.-H. The tumor lysis syndrome. N Engl J Med 2011, 364:1844-1854.
201. Mikkelsen T.S., Mamoudou A.D., Tuckuviene R., Wehner P.S., Schroeder H. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study. Pediatr Blood Cancer 2014, 61:297-301.
202. Sand T.E., Jacobsen S. Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol 1981, 19:453-456.
203. Christensen M.L., Rivera G.K., Crom W.R., Hancock M.L., Evans W.E. Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia. J Clin Oncol 1988, 6:797-801.
204. Kinoshita A., Kurosawa Y., Kondoh K., et al. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 2003, 51:256-260.
205. Relling M.V., Fairclough D., Ayers D., et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 1994, 12:1667-1672.
206. Darmon M., Vincent F., Camous L., et al. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique. Br J Haematol 2013, 162:489-497.
207. Galardy P.J., Hochberg J., Perkins S.L., Harrison L., Goldman S., Cairo M.S. Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report. Br J Haematol 2013, 163:365-372.
208. Shimada M., Johnson R.J., May W.S., et al. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant 2009, 24:2960-2964.
209. Lopez-Olivo M.A., Pratt G., Palla S.L., Salahudeen A. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis 2013, 62:481-492.
210. Cheuk D.K., Chiang A.K., Chan G.C., Ha S.Y. Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer. Cochrane Database Syst Rev 2010, 6:CD006945.
211. Cortes J., Moore J.O., Maziarz R.T., et al. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone - results of a multicenter phase III study. J Clin Oncol 2010, 28:4207-4213.
212. Goldman S.C., Holcenberg J.S., Finklestein J.Z., et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001, 97:2998-3003.
213. Coiffier B., Altman A., Pui C.-H., Younes A., Cairo M.S. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008, 26:2767-2778.
214. Cairo M.S., Coiffier B., Reiter A., Younes A., TLS Expert Panel Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010, 149:578-586.
215. Will A., Tholouli E. The clinical management of tumour lysis syndrome in haematological malignancies. Br J Haematol 2011, 154:3-13.
216. Druml W. Nutritional support in acute renal failure. Handbook of Nutrition and the Kidney 2005, 95-114. Lippincott Williams & Wilkins, Philadelphia. 5th ed.
217. Fiaccadori E., Cremaschi E., Regolisti G. Nutritional assessment and delivery in renal replacement therapy patients. Semin Dial 2011, 24:169-175.
218. Cano N., Aparicio M., Brunori G., Carrero J.J., Cianciaruso B., Fiaccadori E., et al. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr 2009, 28:401-414.
219. Fiaccadori E., Parenti E., Maggiore U. Nutritional support in acute kidney injury. J Nephrol 2008, 21:645-656.
220. Bellomo R., Tan H.K., Bhonagiri S., et al. High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs 2002, 25:261-268.
221. Berger M.M., Shenkin A., Revelly J.P., et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004, 80:410-416.
222. Mammen C., Al Abbas A., Skippen P., et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 2012, 59:523-530.
223. Wald R., Quinn R.R., Adhikari N.K., et al. Risk of chronic dialysis and death following acute kidney injury. Am J Med 2012, 125:585-593.
224. Pannu N., James M., Hemmelgarn B., Klarenbach S., Alnerta Kidney Disease Networ@k Association between AJI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol 2013, 8:194-202.
225. Harel Z., Wald R., Bargman J.M., et al. Nephrologists follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int 2013, 83:901-908.